Mometason Stada Bei Heuschnupfen Stada (Mometasone Furoate)

Mometasone furoate acts as an agonist of the glucocorticoid receptor in nasal mucosal cells. By binding to this receptor, it modifies gene expression to suppress the production of inflammatory cytokines, chemokines and other mediators, thereby reducing swelling and irritation in the nasal passages.

The exact dosing regimen for Mometason Stada is determined by the prescribing clinician based on the patient’s age, severity of symptoms and response to therapy. Typical adult dosing may involve one or two sprays per nostril once daily, but the prescriber’s instructions must always be followed.

Safety data for mometasone furoate nasal spray in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss the medication with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials. The sales team will then respond with pricing, availability, shipping details and any necessary import documentation.

Mometason Stada contains mometasone furoate, which is a high‑potency intranasal corticosteroid with a low systemic bioavailability. Compared with alternatives such as fluticasone propionate, mometasone often provides comparable symptom control with a similar safety profile, though individual response may vary and the choice depends on clinician preference and patient factors.

The nasal spray should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and avoid freezing. Do not use the product after the expiration date printed on the label.

Before the first use, prime the spray by pressing the actuator several times until a fine mist appears. Tilt the head slightly forward, insert the tip into one nostril, close the opposite nostril with a finger, and gently spray the prescribed number of sprays while breathing in slowly. Repeat in the other nostril if directed.

Serious but rare risks include nasal septal perforation, severe nosebleeds, adrenal suppression, opportunistic fungal infections of the nasal mucosa, and hypersensitivity reactions such as anaphylaxis. Vision changes such as cataract or glaucoma have also been reported with prolonged high‑dose use. Patients should seek medical attention if any of these occur.

Mometason Stada should be avoided in individuals with known hypersensitivity to mometasone furoate or any component of the formulation. It is also contraindicated in patients with active untreated nasal or sinus infections, recent nasal surgery, or those who have experienced nasal septal perforation. A healthcare professional should evaluate suitability before initiating therapy.